| The integration of radiotherapy with immunotherapy for the treatment of non–small cell lung cancer EC Ko, D Raben, SC Formenti Clinical Cancer Research 24 (23), 5792-5806, 2018 | 241 | 2018 |
| Targeting immune suppressing myeloid-derived suppressor cells in oncology J Kao, EC Ko, S Eisenstein, AG Sikora, S Fu, S Chen Critical reviews in oncology/hematology 77 (1), 12-19, 2011 | 186 | 2011 |
| Radiotherapy and checkpoint inhibitors: a winning new combination? EC Ko, SC Formenti Therapeutic advances in medical oncology 10, 1758835918768240, 2018 | 102 | 2018 |
| Myeloid-derived suppressor cells as an immune parameter in patients with concurrent sunitinib and stereotactic body radiotherapy HM Chen, G Ma, N Gildener-Leapman, S Eisenstein, BA Coakley, J Ozao, ... Clinical Cancer Research 21 (18), 4073-4085, 2015 | 101 | 2015 |
| Epidemiology of head and neck squamous cell cancer among HIV-infected patients G D'Souza, TE Carey, WN William Jr, ML Nguyen, EC Ko, J Riddell IV, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 65 (5), 603-610, 2014 | 86 | 2014 |
| An immunochemical study on tau glycation in paired helical filaments L Ko, EC Ko, P Nacharaju, WK Liu, E Chang, A Kenessey, SHC Yen Brain research 830 (2), 301-313, 1999 | 84 | 1999 |
| Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases CCL Tong, EC Ko, MW Sung, JA Cesaretti, RG Stock, SH Packer, ... PloS one 7 (6), e36979, 2012 | 78 | 2012 |
| Immunotherapy of Malignant DiseasesChallenges and Strategies EC Ko, X Wang, S Ferrone International archives of allergy and immunology 132 (4), 294-309, 2003 | 69 | 2003 |
| Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality EC Ko, SC Formenti International Journal of Radiation Biology 95 (7), 936-939, 2019 | 64 | 2019 |
| Generating antitumor immunity by targeted radiation therapy: role of dose and fractionation EC Ko, KT Benjamin, SC Formenti Advances in radiation oncology 3 (4), 486-493, 2018 | 62 | 2018 |
| Direct measurement of islet amyloid polypeptide fibrillogenesis by mass spectrometry JL Larson, E Ko, AD Miranker Protein Science 9 (2), 427-431, 2000 | 62 | 2000 |
| Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effects W Luo, E Ko, JC Hsu, X Wang, S Ferrone The Journal of Immunology 176 (10), 6046-6054, 2006 | 48 | 2006 |
| Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies X Wang, M Campoli, E Ko, W Luo, S Ferrone Journal of immunological methods 294 (1-2), 23-35, 2004 | 39 | 2004 |
| PSA nadir of< 0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure EC Ko, NN Stone, RG Stock International Journal of Radiation Oncology* Biology* Physics 83 (2), 600-607, 2012 | 38 | 2012 |
| γ-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizers S Fu, Y Yang, D Tirtha, Y Yen, B Zhou, MM Zhou, M Ohlmeyer, EC Ko, ... PloS one 7 (6), e38465, 2012 | 32 | 2012 |
| Differential immunogenicity of two peptides isolated by high molecular weight-melanoma-associated antigen-specific monoclonal antibodies with different affinities W Luo, JC Hsu, CY Tsao, E Ko, X Wang, S Ferrone The Journal of Immunology 174 (11), 7104-7110, 2005 | 31 | 2005 |
| Radiobiological rationale and clinical implications of hypofractionated radiation therapy EC Ko, K Forsythe, M Buckstein, J Kao, BS Rosenstein Cancer/Radiothérapie 15 (3), 221-229, 2011 | 29 | 2011 |
| Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal … X Wang, EC Ko, L Peng, SD Gillies, S Ferrone Cancer research 65 (15), 6976-6983, 2005 | 29 | 2005 |
| Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation EC Ko, EM Genden, K Misiukiewicz, PM Som, L Kostakoglu, CT Chen, ... Oncology reports 27 (2), 467-474, 2012 | 25 | 2012 |
| Combined inhibition of epidermal growth factor receptor and cyclooxygenase-2 as a novel approach to enhance radiotherapy S Fu, M Rivera, EC Ko, AG Sikora, CT Chen, HL Vu, D Cannan, ... Journal of cell science & therapy 1 (2), 2011 | 24 | 2011 |
